Kuehl, P. J., Tellez, C. S., Grimes, M. J., March, T. H., Tessema, M., Revelli, D. A., . . . Belinsky, S. A. (2020). 5-Azacytidine inhaled dry powder formulation profoundly improves pharmacokinetics and efficacy for lung cancer therapy through genome reprogramming. Br J Cancer.
استشهاد بنمط شيكاغوKuehl, Philip J., et al. "5-Azacytidine Inhaled Dry Powder Formulation Profoundly Improves Pharmacokinetics and Efficacy for Lung Cancer Therapy Through Genome Reprogramming." Br J Cancer 2020.
MLA استشهادKuehl, Philip J., et al. "5-Azacytidine Inhaled Dry Powder Formulation Profoundly Improves Pharmacokinetics and Efficacy for Lung Cancer Therapy Through Genome Reprogramming." Br J Cancer 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.